RSVP NOW: Claritas Rx Cocktail Reception at Asembia 2026 🍸🍹

Thought Leadership

Stay in the know with content from industry experts.

The Omnichannel Gap: Building the CRM of the Future for Patient Services

Specialty therapies demand more than just tracking—they require a total patient management system. Most traditional CRMs are built to manage…

WebinarLive Event

The Omnichannel CRM Gap: Empowering the Teams Behind Every Patient

Today’s biopharma leaders are expected to deliver seamless, high-touch patient experiences across channels — but outdated CRMs and fragmented systems…

Data to Action A 5‑Step Playbook for Specialty Therapy Commercial Teams

eBook

Data to Action: A Step-by-Step Playbook for Specialty Therapy Commercial Teams

Unlock transparent, high‑impact data aggregation for specialty and rare disease. Many specialty therapy manufacturers are navigating fragmented data ecosystems that…

Industry Article

Claritas Rx Featured on BioXconomy

Learn how our integrated data and consent solution drives higher first fill rates and long-term persistence across specialty and rare brands.

Learn More

A healthcare professional interacts with advanced digital interfaces, seamlessly merging technology and patient care in a modern medical environment.

Blog

Turning Rare Disease Data into Action: How AI is Changing the Game

Rare diseases affect approximately 30 million people in the United States, yet the path to diagnosing and treating these conditions remains notoriously…

WebinarOn Demand

Cracking the Black Box: Using Integrated Data, Insights and Consent to Drive First Fill and Long‑Term Persistence

Watch this session designed for commercial, trade and channel, market access, and patient services teams who are frustrated with opaque data…

Learn More

White Paper

Transforming Data Aggregation in Specialty and Rare Disease

Unlock transparent, high‑impact data aggregation for specialty and rare disease. In specialty and rare disease, the biggest data challenge is…

scientist working in laboratory on rare disease treatment development

Blog

Top Specialty Pharma Leaders Reshaping the Rare Disease Market

The rare disease market has evolved from a fragmented collection of niche therapies into one of the most strategically important…

Doctor touching white cross of healthcare for rare disease diagnosis

Blog

Rare Disease: From Niche Bet to Strategic Imperative for Specialty Pharma

Rare disease has evolved from a niche scientific experiment into a core growth engine for specialty pharma. But that model…

A woman sits in a hospital bed, her gentle expression reflecting resilience as she embraces her healing journey.

Blog

Turning Cell and Gene Therapy Complexity into Clarity: Data, Collaboration, and Patient Impact

There’s no denying that cell and gene therapies (CGTs) are shaping the future of medicine and healthcare as we know it. The global CGT…

Blog

When Rare Isn’t Rare: A Snapshot of the Global Rare Disease Burden

The Global and Personal Burden of Rare Diseases Rare diseases collectively affect hundreds of millions of people worldwide, yet each…

White Paper

Thriving in Turbulence: Strategic Adaptation in the Evolving Specialty and Rare Market

The Five Market Trends Shaping 2026 In specialty and rare disease markets, even small shifts in demand, coverage, or supply…